Are you Dr. Middleton?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1199 Prince Ave
Athens, GA 30606Phone+1 706-475-5076Fax+1 770-410-4664
Summary
- Dr. Mark Middleton, MD is a general surgeon in Athens, Georgia. He is currently licensed to practice medicine in Georgia, Kansas, and Maine. He is affiliated with Piedmont Athens Regional Medical Center and Wellstar North Fulton Hospital.
Education & Training
- Orlando HealthResidency, Surgery, 1996 - 2001
- University of Alabama School of MedicineClass of 1996
Certifications & Licensure
- ME State Medical License 2024 - 2026
- ND State Medical License 2023 - 2026
- GA State Medical License 2004 - 2025
- KS State Medical License 2024 - 2025
- LA State Medical License 2023 - 2025
- AL State Medical License 2001 - 2024
- NE State Medical License 2023 - 2024
- American Board of Surgery Surgery
- American Board of Surgery Surgical Critical Care
- Join now to see all
Clinical Trials
- Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 1999 Jun 01
- Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients Start of enrollment: 2009 Jul 01
- Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma Start of enrollment: 2010 Sep 28
- Join now to see all
Publications & Presentations
PubMed
- Field Placement Correction Using MV IGRT. Is Postintervention Imaging NecessaryHayley Clark, Mark Jones, Debbie Shannon, Toni Sisson, Ashley Plank
Journal of Medical Imaging and Radiation Sciences. 2013-06-01 - 18 citationsSuccessful Implementation of Image-Guided Radiation Therapy Quality Assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT StudyMark Middleton, J. Frantzis, Brendan Healy, Mark Jones, Rebecca Murry
International Journal of Radiation Oncology, Biology, Physics. 2011-12-01
Press Mentions
- Celsion GmbH Announces Commencement of Enrollment in Oxford University’s Phase 1 Study with ThermoDox® and Focused Ultrasound in Pancreatic CancerJuly 1st, 2021
- Cancer Research: What’s Exciting the Experts?May 18th, 2021
- SPCA Raises over R200 000 for Bone Plating KitNovember 19th, 2020
- Join now to see all